Howard W. Robin
2014
In 2014, Howard W. Robin earned a total compensation of $8M as President and Chief Executive Officer at Nektar Therapeutics, a 125% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $1,131,945 |
|---|---|
| Option Awards | $6,022,755 |
| Salary | $860,004 |
| Other | $18,278 |
| Total | $8,032,982 |
Robin received $6M in option awards, accounting for 75% of the total pay in 2014.
Robin also received $1.1M in non-equity incentive plan, $860K in salary and $18.3K in other compensation.
Rankings
In 2014, Howard W. Robin's compensation ranked 764th out of 13,032 executives tracked by ExecPay. In other words, Robin earned more than 94.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 764 out of 13,032 | 94th |
Division Manufacturing | 279 out of 4,967 | 94th |
Major group Chemicals And Allied Products | 91 out of 1,690 | 95th |
Industry group Drugs | 72 out of 1,369 | 95th |
Industry Pharmaceutical Preparations | 66 out of 1,042 | 94th |
Source: SEC filing on April 29, 2016.
Robin's colleagues
We found four more compensation records of executives who worked with Howard W. Robin at Nektar Therapeutics in 2014.